University of Cincinnati

dotardhousesΜηχανική

18 Νοε 2013 (πριν από 3 χρόνια και 11 μήνες)

73 εμφανίσεις

University of Cincinnati

Intellectual Property Office

UC Firsts


First oral polio vaccine


Albert Sabin


First antihistamine, Benadryl


George Rieveschl


First safe anti
-
knock gasoline


First electric organ


Winston Koch


First use of a YAG laser to remove
brain tumor


Mission of Intellectual Property Office


Main Mission
-

Technology Transfer


Assess new invention disclosures


Develop strategies for protecting University’s
IP


Transfer University’s IP to industry for the
public good and commercial gain (increase
society’s wealth locally and nationally)


Promote entrepreneurship through faculty
counseling and referral


Provide University presence within industrial
and investment communities

Technology Transfer Process


Process begins with the submission
of an invention disclosure


Evaluation involves the investigation
of many complex patent/legal,
ownership and business related
questions.


Esp pre
-
existing obligations to sponsor


Ongoing Administrative Obligations


Bayh
-
Dole Compliance


Reporting


Election of Title


Patent Filing Decisions


Invention Utilization


Licensee Diligence


Progress reports


Milestone, royalty payments

Skills Set


Complexity of University Technology Transfer
demands sophisticated knowledge of many
different fields


patent law


licensing & contract law


federal, state, and university polices & laws related to IP



in
-
depth understanding of market trends


capacity to understand new technical developments


We’re fortunate in our office to have a team with a
highly complimentary skills set (PhD, JD, MBA)

Intellectual Property Staff

About Our Office


Approx 75 active licenses


164 active patents


$6.5 million in license revenue in FY02


Over 50% of US patents issued to us in
the last 5 years have been licensed or
optioned to industry


Top 1/3 of Technology Transfer Offices
nationwide, top office in tri
-
state

Invention Disclosures and Patents

0
10
20
30
40
50
60
70
80
90
100
FY 98
FY 99
FY 00
FY 01
FY 02
Invention
Disclosure
Issued US Patents
Licensing Income

$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
$7.00
FY 98
FY 99
FY 00
FY 01
FY 02
License Income
(million $)
UC IP Helping to Advance Local Firms


Small Firms


KY Pharmaceutical firm


Considering license to slow
-
release diuretic technology
and sponsoring research to develop the product. Also
considering re
-
locating R&D from KY to Bio/Start


Local Medical Device firm


Considering license to early stroke diagnostic technology
and also sponsoring research at UC to develop the
medical device


Local Biosensor firm


Interested in acquiring a license to our biosensor
technology and partnering with us on development
environment monitoring equipment


UC Helping Cont’d


Large Firms


P&G Pharmaceuticals


Collaborative research in area of obesity


Halliburtin


Oil drilling technology


GE


Aerospace technology


Example Recent License Agreement


Inventors
-

Drs. Joseph Clark (UC) and Ton
Degrauw (Children’s Hospital) and Rima Daouk
(Avicena)


Licensee
-

Avicena (Biotech in Cambridge, MA)


Invention
-

Discovered that a mutations in gene
that encodes creatine transport protein located on
X chromosome (afflicts males) can cause mental
retardation


Currently working on a cure


License complemented with sponsored research
agreement designed to determine prevalence of
this defect and to identify therapeutics


Examples of Faculty Start
-
ups


Extreme Photonics (solid
-
state display)


Apologic (develops drugs for Apo
-
E related
diseases, e.g., Alzheimer’s)


CardioEnergetics (mechanical devices for treating
heart failure)


Cutanogen (skin substitutes)


Allergenics (oral vaccines)


Phase 2 Discovery (develops drugs for treating
psychiatric and neurologic disorders)


Intracellular (cellular imaging instruments)

Extreme Photonics


"Extreme" Engineering Innovation
Launches High
-
tech Firm



An idea born in the labs of Ohio
Eminent Scholar Andrew Steckl led
to the birth of Cincinnati's newest
high
-
tech company
--

Extreme
Photonix.


The company was started by Steckl,
Gieringer Professor of Solid State
Microelectronics in the electrical and
computer engineering and computer
science department. Research
Corporation Technologies (RCT) of
Tuscon, Ariz., recently announced it
would support the company's
research and development so
prototype products can be made.


Examples of Licensing Opportunities


Pharmacogenomics


Genetic test for asthma and congestive heart patients to
help physician to determine best drug


Diagnostic


Blood test that can diagnosis any neurological disease
(stroke, epilepsy, possibly even Alzheimer’s)


Medical Device


Ultrasonic “clot busting” device for treating stroke


Therapeutic


Patented Cystic Fibrosis drug


Ultrasound Enhances tPA Thrombolysis

Questions

Richard Kordal, Ph.D., Director, IPO

University of Cincinnati

Mail Location 0829

Cincinnati, OH 45267
-
0829

Ph: (513) 556
-
4724

Fax: (513) 558
-
2296

Email: richard.kordal@uc.edu